Visirna aims to be a leading player in the research and development of oligonucleotide therapeutics, focusing on RNAi therapeutics for cardiovascular and metabolic diseases
Visirna aims to be a leading player in the research and development of oligonucleotide therapeutics, focusing on RNAi therapeutics for cardiovascular and metabolic diseases.